Description:Delegates attending this course will benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. Commonly available anti-cancer drugs will be reviewed with emphasis on mode of action, dose intensity and chemotherapy regimes. The range of side effects of cancer treatments will be studied in detail. Quality of life issues in terms of overall assessment and result interpretation will also be discussed.
Detailed consideration will be given to the treatment of major tumor types: breast, lung, melanoma, upper gastrointestinal (GI), colorectal, ovarian, melanoma, and prostate cancer. Each session will be presented by clinicians active in these areas and will focus on overall patient presentation and management and cancer diagnosis and staging. Following these sessions, our experts will lead delegates in interactive group discussions on the key issues relating to effective management of each tumor type.
The limitations of cytotoxic drugs currently available are well known. With this in mind, the course includes in-depth discussion on new drug development and identification of new pharmacological targets of particular interest and value. Clinical trial design issues will also be included.
John Chan, M.D.Director,Gynecologic Oncology,
California Pacific/Palo Alto Medical Foundation Research Institute,
Adjunct Clinical Professor,University of California, San Francisco
Jeffrey Crawford, M.D.George Barth Geller Professor for Research in Cancer.
Chief of Medical Oncology,Duke University Medical Center
Adil Daud, M.D.HS Clinical Professor of Medicine,
Co-Director, Melanoma Program,University of California
Thierry M. Jahan, M.D.Bonnie J. and Anthony Addario,
Endowed Chair in Thoracic Oncology,
Thoracic Oncology Program,UCSF Helen Diller Family Comprehensive Cancer Center
Bert O’Neil, M.D.Associate Professor,
Director, GI Oncology Program,UNC Lineberger Comprehensive Cancer Center
Charles J. Ryan, M.D.Professor of Clinical Medicine and Urology,
Program Leader, Genitourinary Medical Oncology,USCF Helen Diller Family Comprehensive Cancer Center
Melinda L. Telli, M.D.Assistant Professor of Medicine (Oncology),Stanford University Medical Center
Who Should Attend: Healthcare’s courses are designed for both medical and non-medical staff within the pharmaceutical industry. This course is suitable for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel.
Course Venue/Administrative Details: Details on the venue will be announced soon. Full joining instructions will be supplied to registered delegates nearer the date of the course. Accommodation costs are not included in the registration fee.
The registration fee at CHI’s VIP Discount Rate is $3,995 USD (regular rate $4,750 USD). You save 15% off your registration by registering through Cambridge Healthtech Institute (CHI). This includes lunch and refreshments throughout the day. Accommodation costs are not included. Delegates can register on-line or by completing the booking form and returning it together with the appropriate payment to Cambridge Healthtech Institute. Please retain a copy of the booking form for your records. * Please note: This course is organized by Healthcare Education Services and is being co-marketed by Cambridge Healthtech Institute (CHI). By registering through CHI, you save 15% off the registration rate charged by Healthcare Education Services. Please note: No refund/credit of registration fee will be made for any cancellations received less than 20 working days prior to the date of the course. Cancellations made more than 20 working days prior to course date will incur a $175 administration fee. Substitutions may be made at any time. If Healthcare cancels or postpones this event, the registration fee will be refunded. Healthcare will not accept liability for any other costs. Please read our Booking Conditions.
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: email@example.com
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsultingpublications & eNewslettersKnowledge Foundation professional services
executive teamtestimonialschi timelinemailing listcareers